Tracking thinking skills during car t-cell therapy
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study checks how well you can think, remember, and make decisions during a type of cancer treatment called CAR T-cell therapy, and whether these abilities change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of blood cancer called multiple myeloma that has come back or not improved after treatment.
- You are planning to receive a treatment called CAR T-cell therapy.
- You are able to read and understand English.
- You have internet access and a device with a camera, or you can come to the clinic for study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds after you receive CAR-T cell therapy for multiple myeloma. The goal is to learn more about the treatment's effects and how well it works.
This study tests whether special brain exercises can help protect thinking and memory skills during CAR-T cell therapy—a newer cancer treatment for certain blood cancers. Researchers want to see if training your brain during treatment reduces side effects on memory and mental function.
This study looks at how a special type of immunotherapy called CAR-T therapy might affect your thinking skills, memory, and ability to focus. By checking on patients early and often, the team hopes to find simple ways to detect and manage these side effects sooner.
This study looks at how CAR-T cell therapy affects memory and thinking skills in adults with certain types of lymphoma. The results may help doctors understand and support patients better during treatment.
This study looks at how well CAR-T cell therapy works and how safely it can be given to older adults. It is for people whose cancer or related blood condition has come back or did not respond, and who are receiving a standard (commercial) CAR-T product.
This study looks at how CAR T-cell treatment affects thinking, learning, and day-to-day brain function in children and young adults with certain blood cancers. You (and a caregiver) may complete online testing so researchers can track these changes over time and whether support is needed.
Hear when a new CART Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.